clinical trials

clinical trials

featured image of Breakthrough Obesity Drug: 70 Achieve Over 15 Weight Loss

Breakthrough Obesity Drug: 70 Achieve Over 15 Weight Loss

BIOT

🌍 Roche's obesity drug CT-388 shows impressive results in clinical trial, offering hope for weight loss worldwide! 💊💪 ObesitySolution

featured image of Revolutionary AI Platform Speeds Up Cancer Trials

Revolutionary AI Platform Speeds Up Cancer Trials

BIOT

🚀 Paris-based start-up Klineo raises €2m to revolutionize cancer trials, connecting doctors and patients in minutes. 💪🏼🌍

featured image of French Firm Secures €15m Grant for Breakthrough AMD Drug

French Firm Secures €15m Grant for Breakthrough AMD Drug

BIOT

🌊🔬 Seabelife SAS granted €1.5m to develop groundbreaking drug for advanced dry AMD, aiming for clinical trials by Q12026.

featured image of Germany's Bold Move to Boost Clinical Trials

Germany’s Bold Move to Boost Clinical Trials

BIOT

📢 Germany's draft Medical Research Act aims to speed up clinical trials by removing obstacles and streamlining authorization procedures. However, industry stakeholders are disappointed.

featured image of Revolutionary Oral Drug Restores Muscle Function

Revolutionary Oral Drug Restores Muscle Function

BIOT

🔬 NDM Pharma & Aarhus University created NMD670, a drug that enhances communication between neurons and muscles in Myasthenia gravis. 🧠💪

featured image of Roche's €90m Gene Therapy Hub Revolutionizes Research

Roche’s €90m Gene Therapy Hub Revolutionizes Research

BIOT

Roche opens €90m gene therapy development centre in Germany 🏢🧬💉💊 to advance gene therapy research worldwide 🌍.

featured image of Game-Changing Cancer Immunotherapy Deal Unveiled

Game-Changing Cancer Immunotherapy Deal Unveiled

BIOT

📰 Domain Therapeutics and Chime Biologics join forces to develop an anti-CCR8 antibody for cancer immunotherapy! 👥💉 Exciting times ahead! 🤝

featured image of Revolutionary Gene Therapy for Heart Failure: Promising Results!

Revolutionary Gene Therapy for Heart Failure: Promising Results!

BIOT

💉 Bayer's AskBio unit begins Phase II testing of gene therapy AB-1002 for heart failure patients. Promising results!

featured image of Roche Abandons AC Immune Collaboration Returns Drugs

Roche Abandons AC Immune Collaboration Returns Drugs

BIOT

📰 Roche's US subsidiary, Genentech, 🚢 jumps ship on AC Immune after disappointing study results. 🧪🔍 Crenezumab and Semorinemab returned. 💪 AC Immune remains focused on other therapies. 💰📅

featured image of LimmaTech Biologics Secures Exclusive Rights for Breakthrough Vaccine

LimmaTech Biologics Secures Exclusive Rights for Breakthrough Vaccine

BIOT

🔬 LimmaTech Biologics secures license for AbVacc's LBT-SA7 vaccine! Exciting news in the fight against hospital-acquired infections. 💉✨🌍 biotech vaccine